ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "race/ethnicity"

  • Abstract Number: 1854 • ACR Convergence 2021

    Disease Characteristics and Social Determinants in African Americans with Systemic Sclerosis: A Single Center Experience

    Sarah Compton, DeAnna Baker Frost, Richard Silver and Diane Kamen, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Systemic sclerosis (SSc) is a rare autoimmune disease categorized on the basis of skin involvement as either limited or diffuse cutaneous SSc, the latter…
  • Abstract Number: 0616 • ACR Convergence 2021

    Race and Socioeconomic Status and COVID-19 Outcomes in Patients with Rheumatic Diseases: Findings from a Tertiary Care Center in the Deep South

    Adam Taylor, Dongmei Sun, Jeffrey Foster and Maria I. Danila, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: The southern United States is home to a large proportion of non-Hispanic Black Americans, a group which has historically been disproportionately affected by healthcare…
  • Abstract Number: 1933 • ACR Convergence 2021

    Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus (SLE) in United States Patients: Data from the COVID-19 Global Rheumatology Alliance

    Manuel Ugarte-Gil1, Graciela Alarcn2, Andrea Seet3, Zara Izadi3, Ali Duarte-Garcia4, Emily Gilbert5, Maria Valenzuela-Almada6, Leanna Wise7, Jeffrey Sparks8, Tiffany Hsu9, Kristin D'Silva10, Naomi Patel10, Emily Sirotich11, Jean Liew12, Jonathan Hausmann13, Paul Sufka14, Rebecca Grainger15, Suleman Bhana16, Wendy Costello17, Zachary Wallace18, Lindsay Jacobsohn19, Anja Strangfeld20, Elsa Frazão Mateus21, Kimme Hyrich22, Laure Gossec23, Loreto Carmona24, Saskia Lawson-Tovey22, Lianne Kearsley-Fleet25, Martin Schaefer26, Pedro Machado27, Philip Robinson28, Milena Gianfrancesco3 and Jinoos Yazdany3, 1Hospital Guillermo Almenara Irigoyen, Essalud/Universidad Científica del Sur, Lima, Peru, 2University of Alabama at Birmingham, Birmingham, AL, 3University of California San Francisco, San Francisco, CA, 4Mayo Clinic, Rochester, MN, 5Mayo Clinic, Jacksonville, FL, 6Division of Rheumatology, Mayo Clinic, Rochester, MN, 7LAC+USC/Keck Medicine of USC, Pasadena, CA, 8Brigham and Women's Hospital, Boston, MA, 9Brigham and Women's Hospital, Jamaica Plain, MA, 10Massachusetts General Hospital, Boston, MA, 11McMaster University, Hamilton, ON, Canada, 12Boston University, Boston, MA, 13Boston Children's Hospital / Beth Israel Deaconess Medical Center, Cambridge, MA, 14HealthPartners, Eagan, MN, 15University of Otago, Wellington, New Zealand, 16Crystal Run Health, Montvale, NJ, 17Irish Children's Arthritis Network, Bansha, Ireland, 18Massachusetts General Hospital, Newton, MA, 19University of California San Francisco, Antioch, CA, 20Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany, 21Liga Portuguesa Contra as Doenças Reumáticas (LPCDR), Lisbon, Portugal, 22University of Manchester, Manchester, United Kingdom, 23Sorbonne Université; APHP, Rheumatology Department, Pitié-Salpêtrière Hospital, Paris, France, 24Instituto de Salud Musculoesqueltica (InMusc), Madrid, Spain, 25Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom, 26German Rheumatism Research Center, Berlin, Germany, 27Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, United Kingdom, 28Faculty of Medicine, The University of Queensland, Herston, Australia

    Background/Purpose: Hispanic and African American race/ethnicities have been associated with poor COVID-19 outcomes in the general population and in rheumatic disease patients within the COVID-19…
  • Abstract Number: 0619 • ACR Convergence 2021

    Racial and Ethnic Disparities in Pregnancy Outcomes Among Women with Rheumatic Diseases: A Systematic Literature Review and Quantitative Analysis

    Maya Swaminathan1, Gloria Shen2, Irvin Huang2, Diana Louden2, Waqas Tahir3 and Namrata Singh4, 1MultiCare Good Samaritan Hospital, Newcastle, WA, 2University of Washington, Seattle, WA, 3Rochester General Hospital, Rochester, MN, 4University of Washington, Bellevue, WA

    Background/Purpose: Women are disproportionately affected by rheumatic diseases (RD), with many of them carrying the diagnosis in their childbearing years. Pregnant women with RD have…
  • Abstract Number: PP07 • ACR Convergence 2021

    How Online Spanish-Language Resources Got Me and My RA Through the COVID-19 Pandemic

    Wigna Cruz, Puerto Rico

    Background/Purpose: I was experiencing joint pain especially in my wrists, which led me to see my physician for testing. Initially I was misdiagnosed with lupus.…
  • Abstract Number: 0621 • ACR Convergence 2021

    Case Series of IgG4-related Disease in African American Patients at Two Large Academic Centers

    Jonathan Thaler1, Sunita Dia2 and Florina Constantinescu2, 1MedStar Georgetown University Hospital, Washington, DC, 2Medstar Washington Hospital Center, Washington, DC

    Background/Purpose: IgG4-related Disease (IgG4-rD) is a fibroinflammatory disease with highly variable manifestations that can be difficult to diagnose. Response to treatment with prednisone and/or rituximab…
  • Abstract Number: 0956 • ACR Convergence 2021

    Racial Disparities in Renal Outcomes over Time Among Hospitalized Children with SLE and Effects of Hospital Minority Composition

    Joyce Chang1, Cora Sears2, Veronica Torres3 and Mary Beth Son1, 1Boston Children's Hospital, Brookline, MA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3Temple University, Bucks County, PA

    Background/Purpose: Racial and ethnic minorities are disproportionately affected by pediatric-onset SLE and have worse outcomes compared to their white counterparts. With ongoing advances in pediatric…
  • Abstract Number: 1023 • ACR Convergence 2021

    Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network

    William Nowell1, Edward L. Barnes2, Nupur Parikh1, Shilpa Venkatachalam1, Michael Kappelman2, Jeffrey Curtis3, Peter Merkel4, Dianne Shaw5, Kalen Young5 and Michael George4, 1Global Healthy Living Foundation, Upper Nyack, NY, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 4University of Pennsylvania, Philadelphia, PA, 5Vasculitis Foundation, Kansas City, MO

    Background/Purpose: Ensuring adequate representation of racial/ethnic minorities in research necessitates understanding the prevalence of rheumatic and musculoskeletal diseases in these populations. We sought to evaluate…
  • Abstract Number: 0326 • ACR Convergence 2021

    Apolipoprotein L1 (APOL1) in African-American SLE: Frequency and Clinical Associations

    Michelle Petri1, Romy Kallas2, Jessica Li3, Laurence Magder4 and Daniel Goldman1, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Lankenau Medical Center, Lankenau, PA, 3Johns Hopkins University, Baltimore, MD, 4University of Maryland, Baltimore, Baltimore, MD

    Background/Purpose: The APOL1 gene is implicated in induction of TLR3 agonists and interferons as well as in autophagy. Two genetic variants, G1 (2 single nucleotide…
  • Abstract Number: 1034 • ACR Convergence 2021

    Racial/ethnic Differences in Lupus Pregnancy Outcomes over 1 Decade: A US National Study

    Bella Mehta1, Yiming Luo2, Deanna Jannat-Khah3, Jiehui Xu4, Lisa Sammaritano3, Jane Salmon3, Michael Lockshin1, Susan Goodman3 and Said Ibrahim5, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2National Institutes of Health, Bethesda, MD, 3Hospital for Special Surgery, New York, NY, 4Weill Cornell Medicine, New York, NY, 5Weill Cornell Medicine, Cleveland, OH

    Background/Purpose: Systemic lupus erythematosus (SLE) disproportionately affects women and minorities of childbearing age. Although maternal and fetal outcomes of pregnancy among women with SLE have…
  • Abstract Number: 0554 • ACR Convergence 2020

    Increased Burden of Painful Arthritis and Rheumatism Following the Chikungunya Epidemic 2006: India Rural Population Survey 2018

    Arvind Chopra1, Ravi Ghorpade2, Anuradha Venugopalan1, Manjit Saluja1 and Kiran Adam1, 1Center for Rheumatic Diseases, Pune, India, 2Center for Rheumatic Diseases, Pune

    Background/Purpose: A spectrum of post Chikungunya (Chik) arthritis , often RA like, were referred to an urban rheumatology centre (Pune India)during the 2006 epidemic (Arthritis…
  • Abstract Number: 0560 • ACR Convergence 2020

    Mortality Burden of Immune-Mediated Inflammatory Diseases (IMID): Race/Ethnicity, Sex, and Geographic Variation in the United States

    Ram Singh1, Eric Yen2 and Meifang Wu2, 1UCLA David Geffen School of Medicine, Los Angeles, CA, 2UCLA, Los Angeles, CA

    Background/Purpose: Almost every organ system can be affected by immune-mediated inflammatory diseases (IMID) characterized by inflammation and therapeutic response to immune-suppressive or anti-inflammatory drugs. Since…
  • Abstract Number: 0001 • ACR Convergence 2020

    Management of Rheumatic Diseases During COVID-19: A National Veterans Affairs Survey of Rheumatologists

    Jasvinder Singh1, John Richards2, Elizabeth Chang3, Amy Joseph4 and Bernard Ng5, 1University of Alabama at Birmingham, Birmingham, AL, 2Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 3PVAHCS, Phoenix, AZ, 4Washington University / St. Louis VA, Saint Louis, MO, 5VA Puget Sound HCS, Seattle, WA

    Background/Purpose: To assess the experience, views and opinions of rheumatology providers at Veterans Affairs (VA) facilities about rheumatic disease healthcare issues during the COVID-19 pandemic.Methods:…
  • Abstract Number: 0929 • ACR Convergence 2020

    The Effect of Mycophenolate Mofetil on Pulmonary Function Tests in Patients with Systemic Sclerosis-associated Interstitial Lung Disease, and the Difference Between the African Americans versus Non-African Americans

    Afroditi Boulougoura1, Shannon Lance2, Duncan Moore3, Haijun Wang4, Julio Huapaya5 and Virginia Steen3, 1Department of Internal Medicine, Medstar Georgetown University Hospital, Washington, DC, USA., Washington, DC, 2Department of Internal Medicine, Medstar Georgetown University Hospital, Washington, DC, USA., Washington, 3Division of Rheumatology, Department of Medicine, MedStar Georgetown University Hospital, Washington, DC, 4MedStar Health Research Institute, Washington, DC, USA, Washington, 5Department of Critical Care Medicine, National Institutes of Health, Bethesda, MD, USA., Bethesda

    Background/Purpose: Scleroderma-related interstitial lung disease (SSc-ILD) is a pulmonary fibrosing disorder characterized by systemic inflammation and progressive scarring of the lungs that leads to respiratory…
  • Abstract Number: 0044 • ACR Convergence 2020

    Characterization of Racial Disparities in Rheumatoid Arthritis Treatment Choice and Location of Care

    Elston He1, Eli Cornblath2, Pratyusha Yalamanchi3, Alexis Ogdie2, Joshua Baker2 and Michael George2, 1Synovium, Inc., Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3Michigan Medicine, Ann Arbor, MI

    Background/Purpose: Racial disparities in access to care and treatment regimens exist but remain poorly characterized in the rheumatoid arthritis (RA) patient population. Previous studies using…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology